DHX15 contributes as a cancer promoter in breast cancer, prostate cancer, acute myeloid leukemia, and hepatocellular carcinoma, and as an antitumor factor in glioma due to its growth inhibitory function [12,13,14,15,16]. The gene discussed is DHX15; the disease is central nervous system cancer.